Kayla Zydeck

Retinoid X receptor agonist LG100268 modulates the immune microenvironment in preclinical breast cancer models

M. Sporn, K. Liby, Di Zhang, 2019, npj Breast Cancer.

Chemoprevention of Preclinical Breast and Lung Cancer with the Bromodomain Inhibitor I-BET 762

M. Sporn, K. Liby, Di Zhang, 2017, Cancer Prevention Research.

Retinoid X receptor agonist LG100268 modulates the immune microenvironment in preclinical breast cancer models

M. Sporn, K. Liby, Di Zhang, 2019, npj Breast Cancer.

Chemoprevention of Preclinical Breast and Lung Cancer with the Bromodomain Inhibitor I-BET 762

M. Sporn, K. Liby, Di Zhang, 2017, Cancer Prevention Research.